It is postulated that bacterial lipopolysaccharide (LPS) stimulates IL-6 production and thus up-regulates hepcidin release leading to hypoferremia, [7], [52] as reported in human endotoxemia models [36]. The gene discussed is IL6; the disease is serum lipopolysaccharide activity.